 protocol safe administr debrisoquin biochem epidemiolog research protocol hospit patient abil antihypertens drug debrisoquin genet risk factor primari carcinoma lung hypothesi metabol drug case control studi subject abil debrisoquin test dose drug collect urin sampl laboratori analysi follow group extens intermedi poor metabol poor metabol popul unabl drug group risk deleteri effect medic protocol patient educ blood pressur monitor medic group patient cancer poor metabol small decreas systol diastol blood pressur signific hypotens episod clinic sequela group data debrisoquin control clinic set use character lung cancer patient biochem epidemiolog studi